McKimm-Breschkin JL, Hay AJ, Cao B, Cox RJ, Dunning J, Moen AC, Olson D, Pizzorno A, Hayden FG. COVID-19, Influenza and RSV: Surveillance-informed prevention and treatment - Meeting report from an isirv-WHO virtual conference. Antiviral Res. 2022 Jan;197:105227. doi: 10.1016/j.antiviral.2021.105227; https://pubmed.ncbi.nlm.nih.gov/34933044/
Fjelltveit EB, Cox RJ, Kittang BR, Blomberg B, Buanes EA; Group Bergen COVID-19 Research, Langeland N, Mohn KG. Lower antibiotic prescription rates in hospitalized COVID-19 patients than influenza patients, a prospective study. Infect Dis (Lond). 2022 Feb;54(2):79-89; https://pubmed.ncbi.nlm.nih.gov/34525895/
2022
2021
Amdam H, Madsen A, Zhou F, Bansal A, Trieu MC, Cox RJ. Functional and Binding H1N1pdm09-Specific Antibody Responses in Occasionally and Repeatedly Vaccinated Healthcare Workers: A Five-Year Study (2009-2014). Front Immunol. 2021 Dec 6;12:748281. doi: 10.3389/fimmu.2021.748281; https://www.frontiersin.org/articles/10.3389/fimmu.2021.748281/full
Bansal A, Trieu M-C, Mohn KGI, Cox RJ. Safety, Immunogenicity, Efficacy and Effectiveness of Inactivated Influenza Vaccines in Healthy Pregnant Women and Children Under 5 Years: An Evidence-Based Clinical Review. Frontiers in Immunology. 2021;12(3926); https://www.frontiersin.org/articles/10.3389/fimmu.2021.744774/full
Blomberg B, Mohn KG, Brokstad KA, et al. Cox RJ, Langeland N. Long COVID in a prospective cohort of home-isolated patients. Nat Med; https://pubmed.ncbi.nlm.nih.gov/34163090/
Trieu MC, Bansal A, Madsen A, et al. Cox RJ . SARS-CoV-2-Specific Neutralizing Antibody Responses in Norwegian Health Care Workers After the First Wave of COVID-19 Pandemic: A Prospective Cohort Study. J Infect Dis. 2021;223(4):589-599; https://pubmed.ncbi.nlm.nih.gov/33247924/
Kuwelker K, Zhou F, Blomberg B, et al. Cox RJ, Langeland N Attack rates amongst household members of outpatients with confirmed COVID-19 in Bergen, Norway: A case-ascertained study. The Lancet Regional Health – Europe. 2021;3; https://pubmed.ncbi.nlm.nih.gov/33871470/
Cox RJ, Brokstad KA, Krammer F, Langeland N, Bergen COVID-19 Research Group. Seroconversion in household members of COVID-19 outpatients. Lancet Infect Dis. 2021;21(2):168; https://pubmed.ncbi.nlm.nih.gov/32553187/
Waldock J, Zheng L, Remarque EJ, et al. Assay Harmonization and Use of Biological Standards To Improve the Reproducibility of the Hemagglutination Inhibition Assay: a FLUCOP Collaborative Study. 2021;6(4):e0056721; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8530177/
Paramsothy A, Lartey Jalloh S, Davies RA, Guttormsen AB, Cox RJ, Mohn KG. Humoral and cellular immune responses in critically ill influenza A/H1N1-infected patients. Scand J Immunol. 2021;94(2):e13045; https://pubmed.ncbi.nlm.nih.gov/33891354/
Madsen A, Jul-Larsen A, Trieu MC, Krammer F, Cox RJ. Persistently high antibody responses after AS03-adjuvanted H1N1pdm09 vaccine: Dissecting the HA specific antibody response. NPJ Vaccines. 2021;6(1):45; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8016826/
2021
2020
Venkatesan S, Myles PR, Bolton KJ, et al. Neuraminidase Inhibitors and Hospital Length of Stay: A Meta-analysis of Individual Participant Data to Determine Treatment Effectiveness Among Patients Hospitalized With Nonfatal 2009 Pandemic Influenza A(H1N1) Virus Infection. J Infect Dis. 2020;221(3):356-366; https://pubmed.ncbi.nlm.nih.gov/31314899/
Riese P, Trittel S, Pathirana RD, Klawonn F, Cox RJ, Guzman CA. Responsiveness to Influenza Vaccination Correlates with NKG2C-Expression on NK Cells. Vaccines (Basel). 2020;8(2); https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7349951/
Pollard AJ, Sauerwein R, Baay M, Neels P, speakers HCT, session c. Third human challenge trial conference, Oxford, United Kingdom, February 6-7, 2020, a meeting report. 2020;66:41-52; https://pubmed.ncbi.nlm.nih.gov/32505512/
Mohn KG, Brokstad KA, Islam S, et al. Cox RJ. Early Induction of Cross-Reactive CD8+ T-Cell Responses in Tonsils After Live-Attenuated Influenza Vaccination in Children. J Infect Dis. 2020;221(9):1528-1537; https://academic.oup.com/jid/article/221/9/1528/5817020
Madsen A, Dai YN, McMahon M, et al. Human Antibodies Targeting Influenza B Virus Neuraminidase Active Site Are Broadly Protective. 2020;53(4):852-863 e857; https://pubmed.ncbi.nlm.nih.gov/32976769/
Madsen A, Cox RJ. Prospects and Challenges in the Development of Universal Influenza Vaccines. Vaccines (Basel). 2020;8(3); https://www.mdpi.com/2076-393X/8/3/361
Lartey S, Zhou F, Brokstad KA, et al. Cox RJ. Live-Attenuated Influenza Vaccine Induces Tonsillar Follicular T Helper Cell Responses That Correlate With Antibody Induction. J Infect Dis. 2020;221(1):21-32; https://pubmed.ncbi.nlm.nih.gov/31250024/
Krammer F, Weir JP, Engelhardt O, Katz JM, Cox RJ. Meeting report and review: Immunological assays and correlates of protection for next-generation influenza vaccines. Influenza Other Respir Viruses. 2020;14(2):237-243; https://pubmed.ncbi.nlm.nih.gov/31837101/
Fjelltveit EB, Cox RJ, Ostensjo J, et al. Point-of-care influenza testing impacts clinical decision, patient flow and length of stay in hospitalized adults. J Infect Dis, https://pubmed.ncbi.nlm.nih.gov/33151320/
Bjork A, Thorlacius GE, Mofors J, et al. Viral antigens elicit augmented immune responses in primary Sjogren's syndrome. Rheumatology (Oxford). 2020;59(7):1651-1661; https://pubmed.ncbi.nlm.nih.gov/31665501/
2020
2019
Tunheim G, Laake I, Robertson AH, et al. Antibody levels in a cohort of pregnant women after the 2009 influenza A(H1N1) pandemic: Waning and association with self-reported severity and duration of illness. Influenza Other Respir Viruses. 2019;13(2):191-200; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6379636/
Trieu MC, Jul-Larsen A, Saevik M, et al. Cox RJ. Antibody Responses to Influenza A/H1N1pdm09 Virus After Pandemic and Seasonal Influenza Vaccination in Healthcare Workers: A 5-Year Follow-up Study. Clin Infect Dis. 2019;68(3):382-392; https://pubmed.ncbi.nlm.nih.gov/29893797/
Madsen A, Azimi L, Tete S, et al. Cox RJ. No evidence of antigenic seniority in hemagglutinin specific antibody responses after adjuvanted pandemic 2009 influenza vaccination. Vaccine X. 2019;2:100029; https://pubmed.ncbi.nlm.nih.gov/31384744/
Islam S, Zhou F, Lartey S, et al. Cox RJ. Functional immune response to influenza H1N1 in children and adults after live attenuated influenza virus vaccination. Scand J Immunol. 2019;90(4):e12801; https://pubmed.ncbi.nlm.nih.gov/31269273/
Lanevski A, Zusinaite E, Shtaida N, et al. Low Temperature and Low UV Indexes Correlated with Peaks of Influenza Virus Activity in Northern Europe during 2010(-)2018. 2019;11(3); https://pubmed.ncbi.nlm.nih.gov/30832226/
Bodin J, Mihret A, Holm-Hansen C, et al. Vitamin D Deficiency is Associated with Increased Use of Antimicrobials among Preschool Girls in Ethiopia. 2019;11(3); https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6471093/
Trieu MC, Zhou F, Lartey SL, Sridhar S, Mjaaland S, Cox RJ. Augmented CD4+ T-cell and humoral responses after repeated annual influenza vaccination with the same vaccine component A/H1N1pdm09 over 5 years. NPJ Vaccines. 2018;3:37; https://pubmed.ncbi.nlm.nih.gov/30131880/
Tete SM, Jul-Larsen A, Rostami S, et al. Cox RJ. Impact of pre-existing immunity on the induction of functional cross-reactive anti-hemagglutinin stalk antibodies following vaccination with an AS03 adjuvanted pandemic H1N1 vaccine. 2018;36(16):2213-2219; https://pubmed.ncbi.nlm.nih.gov/29548607/
Olberg HK, Eide GE, Cox RJ, et al. Antibody response to seasonal influenza vaccination in patients with multiple sclerosis receiving immunomodulatory therapy. Eur J Neurol. 2018;25(3):527-534; https://pubmed.ncbi.nlm.nih.gov/29205701/
Mohn KG, Smith I, Sjursen H, Cox RJ. Immune responses after live attenuated influenza vaccination. Hum Vaccin Immunother. 2018;14(3):571-578; https://pubmed.ncbi.nlm.nih.gov/28933664/
Ianevski A, Zusinaite E, Kuivanen S, et al. Novel activities of safe-in-human broad-spectrum antiviral agents. Antiviral Res. 2018;154:174-182; https://pubmed.ncbi.nlm.nih.gov/29698664/
Brokstad KA, Fredriksen M, Zhou F, et al. Cox RJ. T follicular-like helper cells in the peripheral blood of patients with primary Sjogren's syndrome. Scand J Immunol. 2018:e12679; https://pubmed.ncbi.nlm.nih.gov/29882349/
2018
2017
Trieu MC, Zhou F, Lartey S, et al. Cox RJ Long-term Maintenance of the Influenza-Specific Cross-Reactive Memory CD4+ T-Cell Responses Following Repeated Annual Influenza Vaccination. J Infect Dis. 2017;215(5):740-749; https://pubmed.ncbi.nlm.nih.gov/28007925/
Savic M, Dembinski JL, Laake I, et al. Distinct T and NK cell populations may serve as immune correlates of protection against symptomatic pandemic influenza A(H1N1) virus infection during pregnancy. PLoS One. 2017;12(11):e0188055; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5690673/
Mohn KGI, Zhou F, Brokstad KA, Sridhar S, Cox RJ. Boosting of Cross-Reactive and Protection-Associated T Cells in Children After Live Attenuated Influenza Vaccination. J Infect Dis. 2017;215(10):1527-1535; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5461427/
Manenti A, Tete SM, Mohn KG, et al. Cox RJ. Comparative analysis of influenza A(H3N2) virus hemagglutinin specific IgG subclass and IgA responses in children and adults after influenza vaccination. 2017;35(1):191-198; https://pubmed.ncbi.nlm.nih.gov/27789145/
Jacobsen H, Rajendran M, Choi A, et al. Influenza Virus Hemagglutinin Stalk-Specific Antibodies in Human Serum are a Surrogate Marker for In Vivo Protection in a Serum Transfer Mouse Challenge Model. 2017;8(5); https://pubmed.ncbi.nlm.nih.gov/28928215/
Islam S, Mohn KG, Krammer F, et al. Cox RJ Influenza A haemagglutinin specific IgG responses in children and adults after seasonal trivalent live attenuated influenza vaccination. 2017;35(42):5666-5673; https://pubmed.ncbi.nlm.nih.gov/28899626/
Ebensen T, Debarry J, Pedersen GK, et al. Mucosal Administration of Cycle-Di-Nucleotide-Adjuvanted Virosomes Efficiently Induces Protection against Influenza H5N1 in Mice. Front Immunol. 2017;8:1223; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5624999/
Dembinski JL, Mihret A, Yimer SA, et al. High Prevalence of Humoral and Cellular Immunity to Influenza Viruses in Preschool Children Living in Addis Ababa, Ethiopia. Open Forum Infect Dis. 2017;4(1):ofx026; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5414001/
Andersen TK, Zhou F, Cox RJ, Bogen B, Grodeland G. A DNA Vaccine That Targets Hemagglutinin to Antigen-Presenting Cells Protects Mice against H7 Influenza. J Virol. 2017;91(23); https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5686743/